Engineering Molecular Glue Therapeutics Through Structure-Guided Design to Unlock Novel Targets & Accelerate Pipeline Progression
2:30 pm - Thursday 14th January 2027
- Leveraging structural biology and computational modelling to systematically design and optimize molecular glue therapeutics.
- Unlocking novel disease pathways by targeting proteins previously considered inaccessible to conventional drug discovery approaches.
- Advancing a next-generation pipeline of molecular glue candidates through datadriven discovery and preclinical validation.
